Search
Dr Amen Sibtain

Dr Amen Sibtain

Clinical oncology 03547742

 

  • Bupa Platinum consultant
  • is fee assuredFee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Offers

  • Home chemotherapy

About me

I specialise in the treatment of Gastrointestinal, Hepatobiliary and Head and Neck cancers.
I have particular expertise in chemoradiotherapy, new radiotherapy techniques, including Intensity Modulated Radiotherapy, RapidArc, Gamma Knife Radiosurgery and the CyberKnife. as well as chemotherapy and immunotherapy

Areas of interest

Specialist Sites - Oesophageal; stomach; gastric;small bowel; pancreas; liver; biliary; colon; rectum; anus.
Treatments - Complex radiotherapy; Stereotactic radiotherapy; Radiosurgery; CyberKnife; Intensity Modulated Radiotherapy; Rapid Arc; Volumetric Arc Radiotherapy

Medical secretaries

About me
My qualifications & training
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0002

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (>50)

    HCA - Leaders in Oncology Care (>50)

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

    HCA - Leaders in Oncology Care (5-50)

  • X0001

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 0-7 days - (5-50)

    HCA - Leaders in Oncology Care (5-50)

  • E4510

    Fibreoptic examination of trachea (including biopsy/removal of foreign body) - (5-50)

    HCA - Leaders in Oncology Care (5-50)

  • X0007

    Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (5-50)

    HCA - Leaders in Oncology Care (5-50)

  • X6772

    Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (5-50)

    HCA - Leaders in Oncology Care (5-50)

  • X0008

    Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (5-50)

    HCA - Leaders in Oncology Care (5-50)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    HCA - Leaders in Oncology Care (5-50)

  • X6950

    Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (5-50)

    HCA - Leaders in Oncology Care (1-5)

  • X6910

    Clinical supervision of the planning of a course of simple radiotherapy - (5-50)

    HCA - Leaders in Oncology Care (1-5)

  • A1070

    Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (5-50)

    HCA - Leaders in Oncology Care (1-5)

  • X6771

    Preparation for complex radiotherapy without Intensity Modulated Radiotherapy (IMRT) - (1-5)

    HCA - Leaders in Oncology Care (1-5)

  • A1080

    Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (1-5)

    HCA - Leaders in Oncology Care (1-5)

  • A0380

    Stereotactic radiotherapy (SRT) using GammaKnife or similar SRT technology - (1-5)

    HCA - Leaders in Oncology Care (1-5)

  • XR916

    Surgical removal of cuffed central venous catheter - tunnelled (X-ray guided) - (1-5)

  • XR180

    Ultrasound guided drainage of fluid collection - (1-5)

  • XR630

    Percutaneous nephrostomy - (1-5)

  • X6547

    Delivery of a fraction of simple radiotherapy with intensity modulated radiotherapy (IMRT) - (1-5)

Report this page Edit details

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.